Annual Total Long Term Liabilities
$115.36 M
+$33.58 M+41.06%
31 December 2023
Summary:
TG Therapeutics annual total long term liabilities is currently $115.36 million, with the most recent change of +$33.58 million (+41.06%) on 31 December 2023. During the last 3 years, it has risen by +$96.63 million (+515.67%). TGTX annual total long term liabilities is now at all-time high.TGTX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$268.74 M
+$153.77 M+133.74%
30 September 2024
Summary:
TG Therapeutics quarterly total long term liabilities is currently $268.74 million, with the most recent change of +$153.77 million (+133.74%) on 30 September 2024. Over the past year, it has increased by +$160.12 million (+147.42%). TGTX quarterly long term liabilities is now at all-time high.TGTX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TGTX Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +41.1% | +147.4% |
| 3 y3 years | +515.7% | +2455.8% |
| 5 y5 years | +456.6% | +590.5% |
TGTX Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +515.7% | at high | +2455.8% |
| 5 y | 5 years | at high | +515.7% | at high | +2455.8% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
TG Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $268.74 M(+133.7%) |
| June 2024 | - | $114.97 M(+1.3%) |
| Mar 2024 | - | $113.53 M(-1.6%) |
| Dec 2023 | $115.36 M(+41.1%) | $115.36 M(+6.2%) |
| Sept 2023 | - | $108.62 M(+0.8%) |
| June 2023 | - | $107.73 M(+0.8%) |
| Mar 2023 | - | $106.85 M(+30.6%) |
| Dec 2022 | $81.78 M(+6.1%) | $81.78 M(+1.0%) |
| Sept 2022 | - | $80.96 M(+2.1%) |
| June 2022 | - | $79.31 M(+1.7%) |
| Mar 2022 | - | $77.99 M(+1.2%) |
| Dec 2021 | $77.09 M(+311.4%) | $77.09 M(+633.2%) |
| Sept 2021 | - | $10.52 M(-1.9%) |
| June 2021 | - | $10.72 M(-1.8%) |
| Mar 2021 | - | $10.92 M(-41.7%) |
| Dec 2020 | $18.74 M(-53.1%) | $18.74 M(-26.6%) |
| Sept 2020 | - | $25.53 M(-22.3%) |
| June 2020 | - | $32.86 M(-18.0%) |
| Mar 2020 | - | $40.08 M(+0.3%) |
| Dec 2019 | $39.95 M(+92.8%) | $39.95 M(+2.6%) |
| Sept 2019 | - | $38.92 M(+4.0%) |
| June 2019 | - | $37.41 M(+0.2%) |
| Mar 2019 | - | $37.34 M(+80.2%) |
| Dec 2018 | $20.73 M(+752.6%) | $20.73 M(+767.9%) |
| Sept 2018 | - | $2.39 M(-0.5%) |
| June 2018 | - | $2.40 M(-0.7%) |
| Mar 2018 | - | $2.42 M(-0.6%) |
| Dec 2017 | $2.43 M(+19.4%) | $2.43 M(-0.6%) |
| Sept 2017 | - | $2.45 M(-0.7%) |
| June 2017 | - | $2.46 M(-1.0%) |
| Mar 2017 | - | $2.49 M(+22.2%) |
| Dec 2016 | $2.04 M(+48.4%) | $2.04 M(-0.8%) |
| Sept 2016 | - | $2.05 M(+3.7%) |
| June 2016 | - | $1.98 M(+14.7%) |
| Mar 2016 | - | $1.72 M(+25.6%) |
| Dec 2015 | $1.37 M | $1.37 M(-2.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2015 | - | $1.41 M(-2.6%) |
| June 2015 | - | $1.45 M(-2.6%) |
| Mar 2015 | - | $1.49 M(-2.5%) |
| Dec 2014 | $1.52 M(-12.5%) | $1.52 M(-2.4%) |
| Sept 2014 | - | $1.56 M(-2.4%) |
| June 2014 | - | $1.60 M(-8.8%) |
| Mar 2014 | - | $1.75 M(+0.7%) |
| Dec 2013 | $1.74 M(-59.6%) | $1.74 M(-56.3%) |
| Sept 2013 | - | $3.98 M(-3.3%) |
| June 2013 | - | $4.12 M(-2.3%) |
| Mar 2013 | - | $4.21 M(-2.2%) |
| Dec 2012 | $4.31 M(+30.7%) | $4.31 M(-1.7%) |
| Sept 2012 | - | $4.38 M(-0.3%) |
| June 2012 | - | $4.40 M(-5.8%) |
| Mar 2012 | - | $4.66 M(+41.6%) |
| Dec 2011 | $3.29 M(-84.1%) | $3.29 M(-80.4%) |
| Sept 2011 | - | $16.84 M(+0.7%) |
| June 2011 | - | $16.73 M(+0.7%) |
| Mar 2011 | - | $16.61 M(-19.8%) |
| Dec 2010 | $20.71 M(+348.3%) | $20.71 M(+0.7%) |
| Sept 2010 | - | $20.56 M(+0.6%) |
| June 2010 | - | $20.45 M(+0.3%) |
| Mar 2010 | - | $20.40 M(+341.6%) |
| Dec 2009 | $4.62 M(+11.6%) | $4.62 M(-19.4%) |
| Sept 2009 | - | $5.73 M(+1.4%) |
| June 2009 | - | $5.65 M(+1.4%) |
| Mar 2009 | - | $5.57 M(+34.6%) |
| Dec 2008 | $4.14 M(>+9900.0%) | $4.14 M(+40.3%) |
| Sept 2008 | - | $2.95 M(-0.1%) |
| June 2008 | - | $2.95 M(+810.4%) |
| June 2005 | - | $324.40 K(>+9900.0%) |
| Dec 2000 | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 1999 | $100.00 K(-200.0%) | $100.00 K(-133.3%) |
| Mar 1999 | - | -$300.00 K(+200.0%) |
| Dec 1998 | -$100.00 K | -$100.00 K(0.0%) |
| June 1997 | - | -$100.00 K(-200.0%) |
| Sept 1996 | - | $100.00 K |
FAQ
- What is TG Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for TG Therapeutics?
- What is TG Therapeutics annual total long term liabilities year-on-year change?
- What is TG Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for TG Therapeutics?
- What is TG Therapeutics quarterly long term liabilities year-on-year change?
What is TG Therapeutics annual total long term liabilities?
The current annual total long term liabilities of TGTX is $115.36 M
What is the all time high annual total long term liabilities for TG Therapeutics?
TG Therapeutics all-time high annual total long term liabilities is $115.36 M
What is TG Therapeutics annual total long term liabilities year-on-year change?
Over the past year, TGTX annual total long term liabilities has changed by +$33.58 M (+41.06%)
What is TG Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of TGTX is $268.74 M
What is the all time high quarterly long term liabilities for TG Therapeutics?
TG Therapeutics all-time high quarterly total long term liabilities is $268.74 M
What is TG Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, TGTX quarterly total long term liabilities has changed by +$160.12 M (+147.42%)